Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Berger A, Pedersen J, Kowatsch MM, Scholte F, Lafrance MA, Azizi H, Li Y, Gomez A, Wade M, Fausther-Bovendo H, de La Vega MA, Jelinski J, Babuadze G, Nepveu-Traversy ME, Lamarre C, Racine T, Kang CY, Gaillet B, Garnier A, Gilbert R, Kamen A, Yao XJ, Fowke KR, Arts E, Kobinger G. Berger A, et al. Among authors: arts e. Vaccines (Basel). 2024 Mar 29;12(4):369. doi: 10.3390/vaccines12040369. Vaccines (Basel). 2024. PMID: 38675751 Free PMC article.
A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.
Kim GN, Choi JA, Wu K, Saeedian N, Yang E, Park H, Woo SJ, Lim G, Kim SG, Eo SK, Jeong HW, Kim T, Chang JH, Seo SH, Kim NH, Choi E, Choo S, Lee S, Winterborn A, Li Y, Parham K, Donovan JM, Fenton B, Dikeakos JD, Dekaban GA, Haeryfar SMM, Troyer RM, Arts EJ, Barr SD, Song M, Kang CY. Kim GN, et al. Among authors: arts ej. PLoS Pathog. 2021 Dec 16;17(12):e1010092. doi: 10.1371/journal.ppat.1010092. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34914812 Free PMC article.
First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.
Choi E, Michalski CJ, Choo SH, Kim GN, Banasikowska E, Lee S, Wu K, An HY, Mills A, Schneider S, Bredeek UF, Coulston DR, Ding S, Finzi A, Tian M, Klein K, Arts EJ, Mann JF, Gao Y, Kang CY. Choi E, et al. Among authors: arts ej. Retrovirology. 2016 Nov 28;13(1):82. doi: 10.1186/s12977-016-0317-2. Retrovirology. 2016. PMID: 27894306 Free PMC article. Clinical Trial.
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.
Ndashimye E, Li Y, Reyes PS, Avino M, Olabode AS, Kityo CM, Kyeyune F, Nankya I, Quiñones-Mateu ME, Barr SD, Arts EJ. Ndashimye E, et al. Among authors: arts ej. J Antimicrob Chemother. 2021 Oct 11;76(11):2965-2974. doi: 10.1093/jac/dkab276. J Antimicrob Chemother. 2021. PMID: 34453542 Free PMC article.
Per-pathogen virulence of HIV-1 subtypes A, C and D.
Bouman JA, Venner CM, Walker C, Arts EJ, Regoes RR. Bouman JA, et al. Among authors: arts ej. Proc Biol Sci. 2023 May 10;290(1998):20222572. doi: 10.1098/rspb.2022.2572. Epub 2023 May 10. Proc Biol Sci. 2023. PMID: 37161335 Free PMC article.
211 results